SABCS Snippets: FDA Approval of Dato-DXd

(22:58)

SABCS Snippets: The Critical Value of Career Development Programs for Women in STEM

(4:22)

SABCS Snippets: Results of the COMET Study (AFT-25)

(7:25)

SABCS Snippets: Results from the OlympiA Trial

(7:8)

SABCS Snippets: Shining a spotlight on Lobular Breast Cancer

(4:23)

SABCS Snippets: After ASCO 2024

(20:17)

SABCS Snippets: Controversies in local regional care

(4:27)

Adjuvant Therapy | 2023 Best of Breast Conference

(46:31)

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02

(14:35)

SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA

(20:40)

39A Reminder | Due Date 21/02/2025 | 15 Cases |

(6:56)

SABCS 2024 Duck Pluck

(2:6)

SABCS Snippets: SHR-A1811 in the Neoadjuvant Treatment of HER2-positive Early Breast Cancer

(5:30)

Year in Review

(2:7:56)

Ask The Expert: SABCS Highlights

(56:30)

Report Back from San Antonio Breast Cancer Symposium (SABCS 2022)

(1:2:6)

State of the Art: Implications of Senescence for Breast Cancer Biology and Treatment

(1:6:24)

SABCS Snippets: Mammographic surveillance in early breast cancer patients over 50

(2:46)

SABCS Snippets: Immunology in Hormone Receptor Positive Breast Cancer

(5:46)

SABCS Snippets: Results from the AFT-38 PATINA Trial

(7:16)

SABCS Snippets: Primary Analysis of HER2CLIMB-02

(4:45)

SABCS Snippets: Five-year outcomes of the IDEA trial

(5:38)

SABCS Snippets: Risk-Reducing Surgeries and Survival in Young BRCA Carriers

(6:)

SABCS Snippets: Results of the EMBER-3 Trial

(6:6)

SABCS Snippets: KEYNOTE-522 Phase 3 Results

(11:45)

SABCS Snippets: The multinational randomized controlled PREFERABLE-EFFECT study

(5:13)

SABCS Snippets: Artificial Intelligence in the Clinic

(6:2)

SABCS Snippets: Magnetic Resonance Imaging and a 12-Gene Expression Assay

(5:55)